KC-based PatientsVoices pulls $150K in first round of seed capital, additional $75K from MTC

July 6, 2018  |  Tommy Felts

Mary Kay O'Connor, PatientsVoices

Competing for a spot in a Nashville-based health tech accelerator, PatientsVoices landed its first round of seed capital — with a booster shot from the State of Missouri.

A $150,000 innovation grant from Jumpstart Foundry investment group represents a leap forward for PatientsVoices, headquartered in iWerx’s North Kansas City entrepreneurial development center, said founder and CEO Mary Kay O’Connor.

“This investment allows us to take our software to the next level so we can serve more healthcare professionals and make a larger impact on the changing face of healthcare in America,” she said, noting the award was part of competition that saw 300 teams narrowed to 12 finalists for the accelerator.

Given the infusion of capital from Tennessee, the Missouri Technology Corporation made good on a commitment to match investments from outside funders, O’Connor said, adding another $75,000 to the mix.

Founded in 2013, PatientsVoices is developing a natural language processing application for analyzing patient feedback. The health tech firm works with hospitals like Children’s Mercy to take qualitative responses that hospitals already collect — comments on surveys, complaints and social media – and send them through the application’s statistical model to identify and label their sentiments accordingly, O’Connor said.

“It uses summary statistics to answer questions like how frequently patients complain about wait time, how satisfied they are with the treatment they receive, and how quickly nurses respond when the patient moves their call button,” she said. “It’s a rich set of data that hospitals don’t currently have access to because they rely primarily on simple satisfaction surveys.”

“What we’re doing is letting patients tell their story,” O’Connor added. “They don’t stick to a script. They don’t stick to a topic.”

The Jumpstart Foundry’s seed-stage healthcare innovation fund offers capital investments as well as access to customers, follow-on capital and an advisory community of like-minded professionals, according to PatientsVoices.

Mary Kay O'Connor, PatientsVoices

Mary Kay O’Connor, PatientsVoices, photo courtesy of KCSourceLink/Travis Young of Austin Walsh Studio

In addition to earlier support and investments from Digital Sandbox KC, the University of Kansas Bioscience and Technology Business Center (BTBC) and Google, PatientsVoices is a recipient of two Phase 1 Small Business Innovation Research grants — for $150,000 and $225,000 — from the National Science Foundation.

In applying for the initial SBIR grant in 2015, O’Connor learned how to tailor her approach to the objectives of the potential funder, she said. The National Science Foundation, for example, emphasizes commercialization potential over the technology behind an application, she said.

“They basically told me, ‘You wouldn’t have gotten this far if you didn’t have a good technical plan. We expect you to implement this, but what’s really important is how you’re going to get your targeted customers to pay you money for what you’re developing because that’s what Congress is ultimately interested in: getting a return on the money agencies invest in small businesses,’” O’Connor recalled.

“That was music to my ears and it really changed how I thought about funding and how we need to spend our time,” she added.

Hospitals are willing to pay for such tech applications because reimbursement rates are falling and they need to attract and retain patients to cover their fixed costs, O’Connor said.

“In the past, their focus was on providing good clinical care — diagnosis, treatment — but now in this new world where patients are becoming more like consumers, the hospitals have to deliver both good medical care and a positive patient experience — from the patients perspective,” she said.

After being awarded a second Phase 1 grant for 2017, PatientsVoices submitted an application for a $750,000 Phase 2 SBIR grant from the National Science Foundation. The company is now awaiting the outcome.

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

2018 Startups to Watch

    stats here

    Related Posts on Startland News

    Ruby Jean's Whole Foods

    Natural fit: Ruby Jean’s opening new juicery inside busy Whole Foods

    By Tommy Felts | July 25, 2019

    The fresh-pressed, multi-year deal to open a brick-and-mortar Ruby Jean’s Juicery inside a high-traffic Whole Foods location puts Chris Goode in a position to scale his clean concept even further beyond Kansas City, he said. “We’re in the healthy food space and Whole Foods has cornered that market pretty broadly. With its parent company now…

    Austin Wilcox and Wondabeka Ashenafi, SERV Nutrition

    Major Kansas City grocery chains stock SERV Nutrition less than a year into business

    By Tommy Felts | July 25, 2019

    Doing good is more than just a motto for SERV Nutrition — it’s the state of the startup’s operation seven months into business, Isaac Collins said as the company’s patented protein pods hit shelves at Price Chopper and Hen House stores across the metro.  “Online sales have been going well, but we saw a great…

    2018 LaunchKC winners

    KCMO turns to entrepreneurs for new ideas on budget support; Advocates to rally at work sessions

    By Tommy Felts | July 25, 2019

    Raised voices and a commitment to civic engagement earned entrepreneurs an additional $350,000 in city support for the 2019 budget year and a second attempt is about to begin, explained Rick Usher.  “It really goes back to when the resident work sessions started in 2018,” Usher, KCMO assistant city manager for entrepreneurship and small business,…

    Tammie Wahaus, ELIAS Animal Health

    Biotech firms: Health innovation can’t grow in KC with wet lab space in such short supply

    By Tommy Felts | July 25, 2019

    ELIAS Animal Health is advancing a technology that can fundamentally change how cancer is treated in both humans and animals, said CEO Tammie Wahaus, yet finding lab space in the metro has been one of the biotech startup’s biggest tests.   “We’re doing a lot of cell culture work, which requires wet lab space, but there…